Efforts Toward Elimination of Infectious Agents in Blood Products. (October 2018)

• Record Type: Journal Article
• Authors: Jacquot, Cyril; Delaney, Meghan
• Is Part Of: Journal of intensive care medicine. Volume 33:Number 10(2018)
• Page Start: 543
• Page End: 550
• Publication Date: 2018-10
• Subjects: transfusion -- blood supply safety -- blood donor testing -- septic transfusion reaction -- pathogen reduction technology; Critical care medicine -- Periodicals; Critical Care -- Periodicals; Soins intensifs -- Périodiques; Soins intensifs; Périodique électronique (Descripteur de forme); Ressource Internet (Descripteur de forme); 616.02805
• DOI: 10.1177/0885066618756589
• Languages: English
• ISSNs: 0885-0666

Abstract

The US blood supply has never been safer. This level of safety depends on a multifaceted approach including blood donor screening, sensitive infectious disease testing, and good manufacturing practice. However, risks remain for transfusion-transmitted infections due to bacterial contamination of platelets and emerging diseases. Thus, ongoing improvements in screening and testing are required. Newer pathogen reduction technologies have shown promise in further ameliorating the safety of the blood supply.